Divestiture

With $400M in 2025 sales, Immunocore now leverages its KIMMTRAK success to fund a high-stakes pivot into broader cancers, HIV, and autoimmune disease.

NKT A/S posts record earnings and a €10B backlog, launching a new strategy and major investments to dominate the booming power cable market.

Posting sector-leading 6.5% organic growth, the testing and certification giant validates its LEAP | 28 strategy with strong profits and a new buyback.

Vow ASA reports record Q4 revenues but shifts strategy to focus on its booming maritime sector, following major write-downs in its industrial division.

After a major trial miss sent its stock tumbling, GRAIL will face investors to pitch its vision for the future of early cancer detection technology.

A report on 69,000 jobs shows Londoners outsource hedge trimming most. The real villain? Ladders, waste removal, and tight urban spaces.

A Florida jury found Publix 100% liable for a fall that led to three spinal surgeries for a young mother, rejecting the company's $600k offer.

Alloy producer Afarak's profits plummet despite rising revenue, revealing the harsh realities of currency woes, cheap imports, and a stalled market.

After a pivotal trial failure, Alector will present its new strategy at a key health conference, focusing on its innovative brain-delivery platform.

The maker of Wegovy and Ozempic announces a massive price cut. We explore what this means for patients, competitors, and the future of drug pricing.

Scotiabank reports a strong start to 2026, with adjusted earnings beating forecasts as international divestitures and domestic growth signal a new focus.

The junior miner sheds non-core assets to double down on its high-grade Mexican silver project while upgrading to a top-tier U.S. market.

Singapore's OUE REIT makes a strategic A$357M entry into Australia, acquiring a stake in Sydney's prime, green-certified Salesforce Tower.

Forvia reports a €2.1B net loss but shows improved operations and cash flow. Is this strategic pain a necessary step toward long-term gain?

Industrial packaging giant Greif rewards shareholders, but a closer look at its finances and dual-class stock reveals a company in major transition.

As corporate dentistry grows, one Ann Arbor practice's shift to woman-owned leadership highlights a demand for personalized, health-focused cosmetic care.

Over 1,000 professionals are in Chicago for the NeighborWorks Training Institute, bringing a $5.2M economic boost and new strategies for the housing crisis.

With vet emergencies costing thousands, a new AKC initiative provides a lifeline to low-income owners facing impossible financial decisions.

A lucrative deal for a rare disease voucher positions Fortress Biotech for profitability, highlighting a successful strategy and a breakthrough for Menkes patients.

As cardiovascular disease affects nearly half of US adults, experts are urging a shift to existing, life-saving therapies that are widely ignored.